Journal of Endocrinology and Metabolism, 45(3), 210-225
J Pharm Exp Ther
This includes reviewing your medications, any recent changes in your health, and answering any last-minute questions
doi: 10.3389/fphar.2025.1509561 Received 11 October 2024 Accepted 27 January 2025 Published 17 February 2025 Volume 16 - 2025 Edited by Ippazio Cosimo Antonazzo, University of Milan-Bicocca, Italy Reviewed by Nafrialdi Nafrialdi, University of Indonesia, Indonesia Marianna Arvanitakis, Universit libre de Bruxelles, Belgium Updates Copyright 2025 He, Li, Cheng, Luo and Huang
Clinical Studies The efficacy of AJOVY was evaluated as a preventive treatment of episodic or chronic migraine in two multicenter, randomized, 3-month, double-blind, placebo-controlled studies (Study 1 and Study 2, respectively)
Watch NBC Bay Area News free wherever you are Hims & Hers Health announced Wednesday it will offer generic semaglutide in Canada as Novo Nordisk's patent on its branded drugs Ozempic and Wegovy is set to expire in January